[Federal Register Volume 83, Number 173 (Thursday, September 6, 2018)]
[Notices]
[Page 45265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-19318]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Investigator-Initiated 
Clinical Trial Implementation Grants (U01) and SBIR Phase II 
Clinical Trial Implementation Grant (U44).
    Date: September 24, 2018.
    Time: 2:30 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Priti Mehrotra, Ph.D., Chief, Immunology Review 
Branch, Scientific Review Program, Division of Extramural 
Activities, Room #3G40, National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20892-7616, 240-669-5066, 
<a href="/cdn-cgi/l/email-protection#33435e565b415c474152735d5a525a571d5d5a5b1d545c45"><span class="__cf_email__" data-cfemail="750518101d071a010714351b1c141c115b1b1c1d5b121a03">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Centers of Excellence for 
Translational Research (CETR) (U19 Clinical Trial Not Allowed).
    Date: September 27-28, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: DoubleTree by Hilton Hotel Bethesda-Washington, DC 
(Formerly Holiday Inn Select), 8120 Wisconsin Avenue, Bethesda, MD 
20814.
    Contact Person: Yong Gao, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, Room 
#3G13B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 
9823, Rockville, MD 20892-7616, (240) 669-5048, <a href="/cdn-cgi/l/email-protection#097066676e276e686649676061276e667f"><span class="__cf_email__" data-cfemail="a0d9cfcec78ec7c1cfe0cec9c88ec7cfd6">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 30, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-19318 Filed 9-5-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>